Brand new: The subsidiary plans to acquire 60% equity of Yilian Medical for 12 million yuan.

New Hope announced on the evening of August 29th that its wholly-owned subsidiary, Zhejiang New Hope Pharmaceutical Co., Ltd., plans to use its own funds of 12 million yuan to acquire 60% equity of Zhejiang Yilian Medical Equipment Co., Ltd. held by Zhejiang Qilian Medical Management Co., Ltd. This transaction will strengthen the foundation of the medical business of New Hope Pharmaceutical, promote the operational hematopoietic ability of New Hope Pharmaceutical, and help improve the overall competitiveness of its subsidiary.